1. Harreiter, J, Roden, M. Diabetes mellitus – definition, klassifikation, diagnose, screening und prävention (update 2019) [Diabetes mellitus-definition, classification, diagnosis, screening and prevention (update 2019)]. Wien Klin Wochenschr. 2019;131(Suppl 1):6-15. doi:10.1007/s00508-019-1450-4.
Google Scholar | Crossref | Medline2. Guariguata, L, Whiting, DR, Hambleton, I, Beagley, J, Linnenkamp, U, Shaw, JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract [Internet]. 2014;103(2):137-149. DOI: 10.1016/j.diabres.2013.11.002.
Google Scholar | Crossref | Medline | ISI3. Ogurtsova, K, da Rocha Fernandes, JD, Huang, Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract [Internet]. 2017;128:40-50. DOI: 10.1016/j.diabres.2017.03.024.
Google Scholar | Crossref | Medline4. Abebaw, M, Messele, A, Hailu, M, Zewdu, F. Global estimates of diabetes prevalence for 2013 and projections for 2035. Int J Africa Nurs Sci [Internet]. 2019;6(4):1-9. DOI: 10.1016/j.diabres.2013.11.002.
Google Scholar | Crossref | Medline5. Dunachie, S, Chamnan, P. The double burden of diabetes and global infection in low and middle-income countries. Trans R Soc Trop Med Hyg. 2019;113(2):56-64. doi:10.1093/trstmh/try124.
Google Scholar | Crossref | Medline6. Animaw, W, Seyoum, Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 2017;12(11):1-11.
Google Scholar | Crossref7. Kerru, N, Singh-Pillay, A, Awolade, P, Singh, P. Current anti-diabetic agents and their molecular targets: a review. Eur J Med Chem. 2018;152:436-488. doi:10.1016/j.ejmech.2018.04.061.
Google Scholar | Crossref | Medline8. Hugtenburg, JG, Timmers, L, Elders, PJM, Vervloet, M, van Dijk, L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675-682.
Google Scholar | Crossref | Medline | ISI9. Hutchins, V, Zhang, B, Fleurence, RL, Krishnarajah, G, Graham, J. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Curr Med Res Opin. 2011;27(6):1157-1168.
Google Scholar | Crossref | Medline | ISI10. Sokol, MC, McGuigan, KA, Verbrugge, RR, Epstein, RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
Google Scholar | Crossref | Medline | ISI11. Chisholm-Burns, MA, Spivey, CA. The “cost” of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc [Internet]. 2012;52(6):823-826. DOI: 10.1331/JAPhA.2012.11088.
Google Scholar | Crossref | Medline12. Abebaw, M, Messele, A, Hailu, M, Zewdu, F. Adherence and associated factors towards antidiabetic medication among type ii diabetic patients on follow-up at university of gondar hospital, Northwest Ethiopia. Adv Nurs. 2016;2016:1-7.
Google Scholar | Crossref13. Alqarni, AM, Alrahbeni, T, Al Qarni, A, Al Qarni, HM. Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia – a cross-sectional survey. Patient Prefer Adherence. 2019;13:63-71.
Google Scholar | Crossref | Medline14. Mikhael, EM, Hussain, SA, Shawky, N, Hassali, MA. Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study. BMJ Open Diabetes Res Care. 2019;7(1):1-7.
Google Scholar | Crossref15. Gelaw, BK, Mohammed, A, Tegegne, GT, et al. Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital. J Diabetes Res. 2014;2014.
Google Scholar | Crossref | Medline16. Khan, A, Al-Abdul Lateef, Z, Al Aithan, M, Bu-Khamseen, M, Al Ibrahim, I, Khan, S. Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. J Fam Community Med. 2012;19(1):26.
Google Scholar | Crossref | Medline17. Farsaei, S, Sabzghabaee, AM, Zargarzadeh, AH, Amini, M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res (IJPR). 2011;10(4):933-939.
Google Scholar | Medline | ISI18. Bagonza, J, Rutebemberwa, E, Bazeyo, W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res. 2015;15:168.
Google Scholar | Crossref | Medline19. Aminde, LN, Tindong, M, Ngwasiri, CA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):1-9.
Google Scholar | Crossref | Medline20. Mirghani, HO . An evaluation of adherence to anti-diabetic medications among type 2 diabetic patients in a sudanese outpatient clinic. Pan Afr Med J. 2019;34:1-9.
Google Scholar | Crossref | Medline21. Wabe, NT, Angamo, MT, Hussein, S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418-423.
Google Scholar | Crossref | Medline22. Boshe, BD, Yimar, GN, Dadhi, AE, Bededa, WK. The magnitude of non-adherence and contributing factors among adult outpatient with Diabetes Mellitus in Dilla University Referral Hospital, Gedio, Ethiopia. PLoS One [Internet]. 2021;16:1-15. DOI: 10.1371/journal.pone.0247952.
Google Scholar | Crossref23. Ali, M, Alemu, T, Sada, O. Medication adherence and its associated factors among diabetic patients at Zewditu Memorial Hospital , Addis Ababa , Ethiopia. BMC Res Notes [Internet]. 2017;10:676. DOI: 10.1186/s13104-017-3025-7.
Google Scholar | Crossref | Medline24. Arifulla, M, John, LJ, Sreedharan, J, Muttappallymyalil, J, Basha, SA. Patients’ adherence to anti-diabetic medications in a Hospital at Ajman. UAE. Malaysian J Med Sci. 2014;21(1):44-49.
Google Scholar | Medline25. Kamuhabwa, AR, Charles, E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf. 2014;6:155-165.
Google Scholar | Crossref | Medline26. Dehdari, L, Dehdari, T. The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes. Arch Public Heal. 2019;77(1):1-9.
Google Scholar | Medline27. Araya, EM, Gebrezgabiher, HA, Tekulu, GH, et al. Medication non-adherence and associated factors among diabetic patients visiting general hospitals in the eastern zone of Tigrai, Northern Ethiopia. Patient Prefer Adherence. 2020;14:2071-2083.
Google Scholar | Crossref | Medline28. Pascal, IGU, Ofoedu, JN, Uchenna, NP, Nkwa, AA, Uchamma, GUE. Blood glucose control and medication adherence among adult type 2 diabetic Nigerians attending a primary care clinic in under-resourced environment of eastern Nigeria. N Am J Med Sci. 2012;4(7):310-315.
Google Scholar | Crossref | Medline29. Krass, I, Schieback, P, Dhippayom, T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725-737.
Google Scholar | Crossref | Medline | ISI30. Adisa, R, Fakeye, TO, Fasanmade, A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in Southwestern Nigeria. Pharm Pract. 2011;9(2):72-81.
Google Scholar | Medline31. Sharma, T, Kalra, J, Dhasmana, D, Basera, H. Poor adherence to treatment: A major challenge in diabetes. J Indian Acad Clin Med. 2014;15(1).
Google Scholar